76N-052N OTC Nasal Decongestants
EMC 70 G Carpenter Vol#: 76
EMC 71 M Moffit Vol#: 76
EMC 72 D Golden Vol#: 76
EMC 73 J Estock Vol#: 76
EMC 74 C Schmidt Vol#: 76
81N-0022 OTC Weight Control Drug Products for Human Use
EMC 15 E Sisson Vol#: 95
EMC 16 G Carpenter Vol#: 95
EMC 17 A Helm Vol#: 95
EMC 18 D Beth Vol#: 95
EMC 19 unsigned Vol#: 95
EMC 20 C Martinsson Vol#: 95
EMC 21 J Hall Vol#: 95
EMC 22 M Carroll Vol#: 95
EMC 23 N Raddie Vol#: 95
EMC 24 Javs Vol#: 95
EMC 25 P Majia Vol#: 95
EMC 26 C Billingsley Vol#: 95
EMC 27 D R Santillo Vol#: 95
EMC 28 Dylan Vol#: 95
EMC 29 J Kaplan Vol#: 95
EMC 30 F Nagy Vol#: 95
EMC 31 N Shriver Vol#: 95
EMC 32 M Arnold Vol#: 95
EMC 33 R Wakefield Vol#: 95
EMC 34 P Marcotti Vol#: 95
EMC 35 J Gillen Vol#: 95
EMC 36 D Pratt Vol#: 95
EMC 37 E Cameron Vol#: 95
EMC 38 J Lynch Vol#: 95
EMC 39 K Crox Vol#: 95
EMC 40 ta Vol#: 95
EMC 41 S Johnson Vol#: 95
EMC 42 t Doogie Vol#: 95
EMC 43 J Estock Vol#: 95
EMC 44 D Golden Vol#: 95
EMC 45 B Porter Vol#: 95
EMC 46 D Clark Vol#: 95
EMC 47 J Stephens Vol#: 95
EMC 48 L Scullion Vol#: 95
EMC 49 R Wedderburn Vol#: 95
EMC 50 S Cooper Vol#: 95
EMC 51 C Francis Vol#: 95
EMC 52 S Ferich Vol#: 95
82F-0349 COPOLYMERS OF DIALLYLDIMETHYLAMMONIUM CHLORIDE
NWL 1 Vol#: 1
90F-0188 Polyethylene phthalate polymers
NWL 1 Vol#: 1
91F-0169 Resinous and Polymeric Coatings
NWL 1 Vol#: 1
91N-0103 Fatty Acids & Heart Disease, Hlth.Claims & Label Statements
REF 2 Reference 1-129 Vol#: 63
93F-0157 SHELL OIL CO.; FILING OF FOOD ADDITIVE PETITION
NWL 1 Vol#: 1
93F-0199 Safe use of maleic anhydride modified hydrogenated styrene
NWL 1 Vol#: 1
94P-0036 Req labeling of trans fatty acid & prohibit deceptive claims
NEC 2 Vol#: 64
95F-0011 Safe use of styrene block copolymer
NWL 1 Vol#: 1
95N-0220 Substances Appoved use in Preparation Meat/Poultry Products
N 1 Vol#: 1
96F-0032 silver-zinc zeolite an agent control growth of microorganism
NWL 1 Vol#: 1
96F-0223 Sodium salt as an emulsifier in production of acrylic & viny
NWL 1 Vol#: 1
96P-0418 Reduce the Precense of Salmonella Enteritidis in Shell Eggs
NFR 1 Vol#: 31
97P-0197 Require that warning labels about risks of salmonella enteri
NFR 1 Vol#: 30
97S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 6205 Country Life Vol#: 49
LET 6206 Country Life Vol#: 49
LET 6207 Twin Laboratories, Inc. Vol#: 49
LET 6208 Twin Laboratories, Inc. Vol#: 49
LET 6209 Golden Temple of Oregon, Inc. Vol#: 49
LET 6210 Country Life Vol#: 49
LET 6211 Country Life Vol#: 49
LET 6212 Pharmavite Corporation Vol#: 49
LET 6213 Country Life Vol#: 49
LET 6214 Country Life Vol#: 49
LET 6215 Young Living Essential Oils Vol#: 49
LET 6216 Country Life Vol#: 49
LET 6217 Country Life Vol#: 49
LET 6218 Country Life Vol#: 49
LET 6219 Country Life Vol#: 49
LET 6220 Country Life Vol#: 49
LET 6221 Sonrich Corporation Vol#: 49
LET 6222 Pharmavite Corporation Vol#: 49
LET 6223 Traditional Medicinals, Inc. Vol#: 49
LET 6224 Weider Nutrition International, Inc. Vol#: 49
LET 6225 Weider Nutrition International, Inc. Vol#: 49
LET 6226 Weider Nutrition International, Inc. Vol#: 49
LET 6227 Weider Nutrition International, Inc. Vol#: 49
LET 6228 Weider Nutrition International, Inc. Vol#: 49
LET 6229 Weider Nutrition International, Inc. Vol#: 49
LET 6230 Weider Nutrition International, Inc. Vol#: 49
LET 6231 Weider Nutrition International, Inc. Vol#: 49
LET 6232 Weider Nutrition International, Inc. Vol#: 49
LET 6233 Weider Nutrition International, Inc. Vol#: 49
LET 6234 Weider Nutrition International, Inc. Vol#: 49
LET 6235 Weider Nutrition International, Inc. Vol#: 49
LET 6236 Weider Nutrition International, Inc. Vol#: 49
LET 6237 Weider Nutrition International, Inc. Vol#: 49
LET 6238 Weider Nutrition International, Inc. Vol#: 49
LET 6239 Weider Nutrition International, Inc. Vol#: 49
LET 6240 Weider Nutrition International, Inc. Vol#: 49
LET 6241 Weider Nutrition International, Inc. Vol#: 49
LET 6242 Weider Nutrition International, Inc. Vol#: 49
LET 6243 Country Life Vol#: 49
LET 6244 Country Life Vol#: 49
LET 6245 Country Life Vol#: 49
LET 6246 Natrol, Inc. Vol#: 49
LET 6247 Country Life Vol#: 49
LET 6248 Country Life Vol#: 49
LET 6249 Country Life Vol#: 49
LET 6250 E'ola International Vol#: 49
LET 6251 Country Life Vol#: 49
98F-0226 Safe Use of Disodium or Dipotassium Fluorescein
NWL 1 Vol#: 1
98F-0288 Food regulations in Olefin Polymers
NWL 1 Vol#: 1
98F-0289 Safe Use of Nylon 6/12 copolymer resins
NWL 1 Vol#: 1
98N-1230 Labeling of Shell Eggs;Shell Eggs: Refrigeration of Shell
NFR 1 Vol#: 32
98P-0151 Introduction Of Downed Cattle Into The Food Supply
C 3141 T Pritchard Vol#: 94
C 3142 D. DuVal Vol#: 94
C 3143 A Lamberti Vol#: 94
C 3144 J Boehm Vol#: 94
C 3145 I. Steinberg, Ph.D. Vol#: 94
C 3146 S Yi Vol#: 94
C 3147 C Mandina Vol#: 94
C 3148 G. Calhoun Vol#: 94
C 3149 S Taffet Vol#: 94
EMC 447 A Kuesel Vol#: 94
EMC 448 R. Smith & Family Vol#: 94
EMC 449 P Stevens Vol#: 94
EMC 450 N Kriegler Vol#: 94
EMC 451 J D'Angelo Vol#: 94
EMC 452 S Carmody Vol#: 94
EMC 453 A Stuck Vol#: 94
EMC 454 S Thurman Vol#: 94
EMC 455 W Smith Vol#: 94
EMC 456 D Towbin Vol#: 94
99F-0052 Ion-exchange resins
NWL 1 Vol#: 1
99F-0460 Production of Olefin Polymers
NWL 1 Vol#: 1
99F-1074 Safe use of Quaternary Amine Cellulose Ion Exchange Resins
NWL 1 Vol#: 1
99F-1719 4-(Diiodomethylsulfonyl) toluene as slimicide food contact
NFL 2 Vol#: 1
99F-2244 Safe use of terpolymer of styrene as an ion-exchange resin
NWL 1 Vol#: 1
99F-2245 Safe use of polymers intended for contact with food
NWL 1 Vol#: 1
99F-5012 Antioxidants and/or Stabilizers for Polymers
NWL 1 Vol#: 1
99N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings
C 16642 R Kahn Vol#: 483
C 16643 C Hawkins Vol#: 483
C 16644 J Detor Vol#: 483
C 16645 S Altom Vol#: 483
C 16646 G Paravati Vol#: 483
C 16647 A. Haase Vol#: 483
C 16648 L Berdnik Vol#: 483
C 16649 J Gipson Vol#: 483
C 16650 T MacDonald Vol#: 483
C 16651 D Hansen Vol#: 483
C 16652 L Wish-Anderson Vol#: 483
C 16653 A. Amaro Vol#: 483
C 16654 M Vahey Vol#: 483
C 16655 E O'Kane Vol#: 483
C 16656 C. Andrews Vol#: 483
C 16657 M Hudak Vol#: 483
C 16658 K. White Vol#: 483
C 16659 E Danko Vol#: 483
C 16660 P. Stefan Vol#: 483
C 16661 A. Johnson Vol#: 483
C 16662 R Matthews Vol#: 483
C 16663 B Anderson Vol#: 483
C 16664 D Cantel Vol#: 483
C 16665 L. Aronson Vol#: 483
C 16666 J. Johnson Vol#: 483
C 16667 T. Flessa Vol#: 483
C 16668 N Tharp Vol#: 483
C 16669 R Stevens Vol#: 483
C 16670 F Matt Vol#: 483
EMC 3304 P Donoghue Vol#: 483
EMC 3305 J Whitley Vol#: 483
EMC 3306 A Ditonno Vol#: 483
EMC 3307 D DiLallo Vol#: 483
EMC 3308 J Smith Vol#: 483
EMC 3309 M Breslin Vol#: 483
EMC 3310 B Berman Vol#: 483
EMC 3311 R Smith Vol#: 483
EMC 3312 J Stevens Vol#: 483
EMC 3313 M Cole Vol#: 483
EMC 3314 G Campbell Vol#: 483
EMC 3315 D. Cinquemani Vol#: 483
EMC 3316 H Shih Vol#: 483
99P-3029 Health Claim: Folic Acid, Vitamin B6 etc & Vascular Disease
LET 6 HFS-800 to Jonathan W. Emord Esq Vol#: 13
REF 1 Reference 1-97 Vol#: 14
00F-0089 Stabilizer in olefin polymers/safe use in food contact
NWL 1 Vol#: 1
00N-1283 Reporting & Recordkeeping Requirements/Electronic Products
NAL 1 Vol#: 1
00N-1440 User Fee Cover Sheet; Form FDA 3397
N 2 Vol#: 1
00N-1463 Labeling Requirements for Systemic Antibacterial Drug Produc
C 6 Bristol-Myers Squibb Pharm. res. Institu Vol#: 1
C 8 State of Michigan Dept. of Community Hlt Vol#: 1
C 9 Procter & Gamble Pharmaceuticals Vol#: 1
C 10 SmithKline Beecham Pharmaceuticals Vol#: 1
C 11 Bayer Pharmaceutical Div. Vol#: 1
C 14 Society Of Infectious Diseases Pharmacis Vol#: 1
C 15 Wythe-Ayerst Labs., a div. Am. Home Prod Vol#: 4
00N-1534 National Surveys Prescriptions Drug Info provide to patients
00N-1571 Enrofloxacin for Poultry: Opportunity for hearing
EMC 2 CSPI Vol#: 16
00N-1575 Nutrition Labeling; Declaration of Caloric Amounts and Servi
N 1 Vol#: 1
00N-1599 Use of Impact-Resistant Lenses in Eyeglasses and Sunglasses
N 1 Vol#: 1
00N-1620 2001 National Antimicrobial Resistance Monitoring System
NM 1 Vol#: 1
00P-0788 Totally Implanted Spinal Cord Stimulator
C 30 Marshfield Clinic Vol#: 4
C 31 ANS, Advanced Neuromodulation Systems, I Vol#: 4
C 32 ANS, Advanced Neuromodulation Systems, I Vol#: 4
00P-1263 Initiation of Procedure to Determine Whether DHEA is exclude
SUP 2 Genelabs Technologies Inc Vol#: 3
00P-1499 Remove alosetron (Lotronex) from the market
EMC 49 B Bardin Vol#: 2
EMC 50 J Stover Vol#: 2
EMC 51 C White Vol#: 2
EMC 52 A Odhner Vol#: 2
EMC 53 R. Stewart, MD Vol#: 2
EMC 54 S. Drews Vol#: 2
EMC 55 M. Fennerty, MD Vol#: 2
EMC 56 L Crowe Vol#: 2
EMC 57 C Mackin Vol#: 2
EMC 58 L Henne Vol#: 2
EMC 59 Consumer Vol#: 2
EMC 60 S Alsted Vol#: 2
EMC 61 M Yard Vol#: 2
EMC 62 C Earl Vol#: 2
EMC 63 M Mosher Vol#: 2
EMC 64 G Berkhofer Vol#: 2
EMC 65 C Condron Vol#: 2
EMC 66 J. Gieske Vol#: 2
EMC 67 Corsentino Vol#: 2
EMC 68 C Patrick Vol#: 2
EMC 69 L Baddley Vol#: 2
EMC 70 Robin MS Vol#: 2
00V-1653 Laser light show
ACK 1 HFA-305 Vol#: 1
VAR 1 Marathon Marketing, LLC Vol#: 1